Step-down of enalapril treatment for arterial hypertension

Hypertension

Volumn 34, Issue 6, 1999, Pages 1287-1292

  González Juanatey, José Ramón ^a   Reino, Antonio Pose ^a   García Acuña, José María ^a   González Juanatey, Carlos ^a   Valdes, Luis ^a   Cabezas Cerrato, José ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Enalapril; Hypertension, arterial; Hypertension, essential

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; QT INTERVAL; TREATMENT OUTCOME;

EID: 0343750715     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.6.1287     Document Type: Article

References (24)

1. Dannenberg AL, Kannel WB. Remission of hypertension: the 'natural' history of blood pressure treatment in the Framingham study. JAMA. 1987;257:1477-1483.
2. Schmieder RE, Rockstroh JK, Messerli FH. Antihypertensive therapy: to stop or not to stop? JAMA 1991;265:1566-1573.
3. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
4. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual process of remodeling and growth. Hypertension. 1993;21:391-397.
5. Gonzàlez-Juanatey JR, Pose A, Garcìa JM, Varela A, Calvo C. Cabezas-Cerrato J. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension. Am J Cardiol. 1998;81:87-90.
6. Gonzàlez-Juanatey JR, Garcìa JM, Pose A, Varela A, Calvo C, Cabezas-Cerrato J, Gil M. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. Am J Cardiol. 1998;81:170-174.
7. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation. 1977;55:613-618.
8. Bazett HC. An analysis of the time relations of electrocardiograms. Heart. 1920;7:353-370.
9. Finnerty FA Jr. Stepped-down therapy versus intermittent therapy in systolic hypertension. Am J Cardiol. 1990;66:1373-1380.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. 1984 report. Arch Intern Med. 1984;144:1045-1057.
11. Langford HG, Blaufox MD, Oberman A, Hawkins CM, Curb JD, Cutter GR, Wassertheil-Smoller S, Pressel S, Babcock C, Abernethy JD. Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA. 1985;253:657-664.
12. Vaur L, Bobrie G, Dutrey-Dupagne C, Dubroca Y, Vaisse B, d'Yvoire BM, Elkik F, Chatellier G, Menard J. Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients. Am J Hypertens. 1998;11:165-173.
13. Gonzàlez-Juanatey JR, Pose A, Garcìa JM, Castelo V, Amaro A, Calvo C, Gil M. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment. Eur Heart J. 1995;16:1981-1987.
14. Page IH, Dustan HP. Persistence of normal blood pressure after discontinuing treatment in hypertensive patients. Circulation. 1962;25:433-436.
15. Thrum RH, Smith WM. On resetting of 'barostats' in hypertensive patients. JAMA. 1967;201:301-304.
16. Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension. 1996;27:1031-1038.
17. Diamond JA, Machac J, Henzlova M, Ardeljan M, Travis A, Wilkenfeld C, Martin KL, Krakoff LR, Phillips RA. Effect of blood pressure reduction on coronary flow reserve in essential hypertension. J Am Coll Cardiol. 1993;21(suppl A):287A. Abstract.
18. Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994;23:83-91.
19. Thurmann PA, Stephens N, Hagerty AM, Kenedi P, Weidinger G, Rietbrock N. Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries. Hypertension. 1996;28:450-456.
20. Brilla CG, Matsubara L, Weller KT. Advanced hypertensive heart disease in spontaneously hypertensive rats: lisinorpil-mediated regression of myocardial fibrosis. Hypertension. 1996;28:269-275.
21. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II forming pathways in normal and failing human hearts. Cir Res. 1990;66:883-890.
22. Gibbon GH. Mechanisms of cardiovascular remodelling: cardioprotective role of ACE inhibition. J Cardiovasc Pharmacol. 1997;30(suppl 1):S1-S9.
23. Bao G, Gohlke P, Qadri F, Unger T. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension. 1992;20:74-79.
24. Kramer HJ, Glanzer K, Meyer-Lehnert H, Mohaupt M, Predel HG. Kininand non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones. J Cardiovasc Pharmacol. 1990;15(suppl 6):S91-S98.